Oncostatin M, a muscle-secreted myokine, recovers high-glucose-induced impairment of Akt phosphorylation by Fos induction in hippocampal neuron cells
- Authors
- Hyung, William Won Seok; Lee, Sung Gon; Kim, Keun Tae; Kim, Hyeon Soo
- Issue Date
- 7-8월-2019
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Keywords
- Akt; c-Fos; ERK; high-glucose; Oncostatin M
- Citation
- NEUROREPORT, v.30, no.11, pp.765 - 770
- Indexed
- SCIE
SCOPUS
- Journal Title
- NEUROREPORT
- Volume
- 30
- Number
- 11
- Start Page
- 765
- End Page
- 770
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/63551
- DOI
- 10.1097/WNR.0000000000001271
- ISSN
- 0959-4965
- Abstract
- Oncostatin M is a muscle-secreted myokine that has various effects on neuronal function, however, the underlying molecular mechanism has been poorly defined. In this study, we showed that Oncostatin M increased the phosphorylation of Akt and ERK, proteins crucial for neuron cell survival and proliferation. Furthermore, Oncostatin M increased the expression of c-Fos, a protein with significant involvement in neuronal cell proliferation and survival, through both Akt and ERK. Oncostatin M also increased intracellular calcium concentrations that act upstream of Akt and ERK. Treatment with Oncostatin M led to the recovery of high-glucose-induced impairment of Akt phosphorylation. Thus, Oncostatin M can protect neuronal cell damage related to high-glucose conditions, showing potential as a therapeutic agent. Copyright (C) 2019 Wolters Kluwer Health, Inc. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.